Modelling Myc inhibition as a cancer therapy.

Nature
L SoucekGerard Evan

Abstract

Myc is a pleiotropic basic helix-loop-helix leucine zipper transcription factor that coordinates expression of the diverse intracellular and extracellular programs that together are necessary for growth and expansion of somatic cells. In principle, this makes inhibition of Myc an attractive pharmacological approach for treating diverse types of cancer. However, enthusiasm has been muted by lack of direct evidence that Myc inhibition would be therapeutically efficacious, concerns that it would induce serious side effects by inhibiting proliferation of normal tissues, and practical difficulties in designing Myc inhibitory drugs. We have modelled genetically both the therapeutic impact and the side effects of systemic Myc inhibition in a preclinical mouse model of Ras-induced lung adenocarcinoma by reversible, systemic expression of a dominant-interfering Myc mutant. We show that Myc inhibition triggers rapid regression of incipient and established lung tumours, defining an unexpected role for endogenous Myc function in the maintenance of Ras-dependent tumours in vivo. Systemic Myc inhibition also exerts profound effects on normal regenerating tissues. However, these effects are well tolerated over extended periods and rapidly and...Continue Reading

References

May 6, 1993·Nature·A R Ferré-D'AmaréS K Burley
May 5, 1997·FEBS Letters·M OkabeY Nishimune
May 8, 1999·The Journal of Investigative Dermatology·D SawamuraI Hashimoto
Sep 17, 1999·Molecular Cell·D W Felsher, J M Bishop
Mar 12, 2002·Advances in Cancer Research·Sara K OsterLinda Z Penn
Jul 6, 2002·Science·Meenakshi JainDean W Felsher
Apr 2, 2004·Expert Review of Anticancer Therapy·Edward V Prochownik
May 15, 2004·Cell Death and Differentiation·L SoucekG I Evan
Dec 21, 2004·Nature Genetics·Alejandro Sweet-CorderoTyler Jacks
Mar 9, 2005·Trends in Cell Biology·Mark J MurphyAndreas Trumpp
Jul 26, 2005·Cancer Letters·Constadina Arvanitis, Dean W Felsher
Nov 17, 2005·Cancer Research·Erica L JacksonTyler Jacks
Nov 14, 2006·Cancer Cell·Gerard I Evan

❮ Previous
Next ❯

Citations

Jul 31, 2013·Cellular and Molecular Life Sciences : CMLS·Leonidas BenetatosEleftheria Hatzimichael
Jan 6, 2010·EMBO Molecular Medicine·Fiona M Watt, Kim B Jensen
Oct 29, 2011·Cellular and Molecular Life Sciences : CMLS·Jonathan R Whitfield, Laura Soucek
May 20, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Chia-Hsin ChanHui-Kuan Lin
Mar 5, 2009·Apoptosis : an International Journal on Programmed Cell Death·John Inge JohnsenMarie Arsenian Henriksson
Feb 1, 2011·Journal of Gastrointestinal Cancer·Anouchka SkoudyPilar Navarro
Aug 23, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·M Dolores DelgadoJavier León
Mar 26, 2013·Molecular Oncology·Jennifer P Morton, Owen J Sansom
Mar 5, 2014·Experimental and Molecular Pathology·Ningning LiuQi Li
Oct 31, 2012·Journal of the American Chemical Society·Sophie R HarveyPerdita E Barran
May 20, 2009·Journal of the American Chemical Society·Jing XuJumi A Shin
Feb 14, 2009·Journal of Medicinal Chemistry·Gabriela MustataIvet Bahar
Feb 4, 2012·Cell Death and Differentiation·M W Gramling, C M Eischen
Aug 5, 2011·Nature·Johannes ZuberChristopher R Vakoc
Oct 25, 2011·Nature Cell Biology·Iris UribesalgoLuciano Di Croce
Nov 22, 2011·Nature Cell Biology·Elisabete M NascimentoMichaela Frye
Sep 25, 2012·Nature Immunology·David Dominguez-SolaRiccardo Dalla-Favera
May 23, 2009·Nature Reviews. Cancer·Jaap Kool, Anton Berns
Aug 25, 2009·Nature Reviews. Cancer·Elizabeth A Musgrove, Robert L Sutherland
Nov 13, 2009·Nature Reviews. Cancer·Tracy A Brooks, Laurence H Hurley
Nov 26, 2009·Nature Reviews. Cancer·Christopher J BrownDavid P Lane
Dec 24, 2009·Nature Reviews. Cancer·Manuel Collado, Manuel Serrano
Jun 23, 2012·Nature Reviews. Cancer·Anna C Belkina, Gerald V Denis
Aug 18, 2012·Nature Reviews. Cancer·Peter K Vogt
Jun 21, 2013·Nature Reviews. Cancer·Philippe JuinMario Campone
Aug 17, 2010·Nature Structural & Molecular Biology·Cyprian D CukierAndres Ramos
Dec 8, 2009·Oncogene·P TrangF J Slack
Mar 20, 2009·Proceedings of the National Academy of Sciences of the United States of America·Markus HartlKlaus Bister
Dec 8, 2009·Proceedings of the National Academy of Sciences of the United States of America·Per HydbringLars-Gunnar Larsson
Aug 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Hua Fan-MinogueSanjiv S Gambhir
Aug 3, 2011·Proceedings of the National Academy of Sciences of the United States of America·Xiaoli ZhangRosalie Sears
Dec 23, 2011·Proceedings of the National Academy of Sciences of the United States of America·Antje MenssenHeiko Hermeking
May 5, 2012·Proceedings of the National Academy of Sciences of the United States of America·Kathryn A O'DonnellJef D Boeke
May 25, 2012·Proceedings of the National Academy of Sciences of the United States of America·Masafumi ToyoshimaCarla Grandori
Jun 6, 2009·The Journal of Biological Chemistry·Jinfei Xu, Joseph R Testa
Jul 22, 2010·The Journal of Biological Chemistry·Tulsiram PrathapamG Steven Martin

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.